April’s top stories: Roche’s prostate cancer test, Medtronic’s divestiture of monitoring business
Roche launched a new diagnostic test called anti-p504s (SP116) Rabbit Monoclonal Primary Antibody for prostate cancer, and Cardinal Health signed a definitive $6.1bn agreement to acquire Medtronic's MIT Group’s patient care, deep vein thrombosis, and nutritional insufficiency businesses. Medicaldevice-network.com wraps-up the key headlines from April 2017.
November 22, 2018